4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001562180-19-005641
Director bought 15,000 shares at $3.52 ($52,800)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Cynthia Director | 2019-11-20 | Purchase | +15,000 | $3.52 | $52,800 | 28,700 | D: show line 1 in the form |
| Open-market purchases · 15,000 sh · avg $3.52 · $52,800 | |||||||
Loading xslF345X03/primarydocument.xml…